The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
Groundbreaking study uncovers the crucial link between REM sleep patterns and Alzheimer's disease, providing new insights for ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...
The Alzheimer's Association Illinois Chapter Junior Board's signature fundraising event Paint The Night Purple is coming up soon. It's an important event to help raise awareness for Alzheimer's ...
The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.